1: Eid H, Institoris E, Geczi L, Bodrogi I, Bak M. Related Articles, Links
mdm-2 expression in human testicular germ-cell tumors and its clinical value.
Anticancer Res. 1999 Jul-Aug;19(4C):3485-90.
PMID: 10629640 [PubMed - indexed for MEDLINE]
2: Mano Y, Kikuchi Y, Yamamoto K, Kita T, Hirata J, Tode T, Ishii K, Nagata I. Related Articles, Links
Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer.
Eur J Cancer. 1999 Aug;35(8):1214-9.
PMID: 10615232 [PubMed - indexed for MEDLINE]
3: Bak M, Geczi L, Institioris E, Eid H, Bodrogi I. Related Articles, Links
[The clinical value of mdm-2 (proto-oncogene) expression in testicular cancer, Correlation with tumor progression]
Orv Hetil. 1999 Aug 15;140(33):1837-40. Hungarian.
PMID: 10489783 [PubMed - indexed for MEDLINE]
4: Darnell G, Richardson DR. Related Articles, Links
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation.
Blood. 1999 Jul 15;94(2):781-92.
PMID: 10397746 [PubMed - indexed for MEDLINE]
5: Lai R, Medeiros LJ, Wilson CS, Sun NC, Koo C, McCourty A, Brynes RK. Related Articles, Links
Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity.
Mod Pathol. 1998 Jul;11(7):642-7.
PMID: 9688185 [PubMed - indexed for MEDLINE]
Time used: 16 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005